InvestorsHub Logo
Followers 61
Posts 11570
Boards Moderated 0
Alias Born 07/16/2006

Re: biotech_researcher post# 17045

Monday, 03/20/2017 9:17:00 PM

Monday, March 20, 2017 9:17:00 PM

Post# of 20689

You would think by EOY??



I see today AstraZenica (who's facilities are supreme compared to Hospira) received another CRL rejecting a drug and one of the reasons was related to manufacturing.

AZN has been working on their warning letter since last May and they thought they had everything resolved at the end of the year. Evidently not.

I'm not sure if the FDA is stricter right now and that could be possible. I hope that Sandoz is looking elsewhere because even if that takes 6-8 months it might be the best option...

Looking at the stock price you can tell the street isn't giving the 'may' option any credibility.